Phenome‑wide profiling identifies genotype‑phenotype associations in Phelan‑McDermid syndrome

Phelan-McDermid syndrome is characterized by global developmental delay, intellectual disability, speech impairment, autism spectrum disorder, and hypotonia; other variable features include epilepsy, brain and renal malformations, and mild dysmorphic features. Here, we conducted genotype-phenotype correlation analyses using the PMS International Registry, a family-driven registry that compiles clinical data in the form of family-reported outcomes and family-sourced genetic test results.

Continue ReadingPhenome‑wide profiling identifies genotype‑phenotype associations in Phelan‑McDermid syndrome

European Consensus Recommendations on Communication, Language and Speech in Phelan-McDermid Syndrome

Phelan-McDermid syndrome is a genetic condition primarily caused by a deletion on the 22q13.3 region or a likely pathogenic/pathogenic variant of SHANK3. The main features comprise global developmental delay, marked impairment or absence of speech, and other clinical characteristics to a variable degree, such as hypotonia or psychiatric comorbidities.

Continue ReadingEuropean Consensus Recommendations on Communication, Language and Speech in Phelan-McDermid Syndrome

European Consensus Recommendations on Altered Sensory Functioning in Phelan-McDermid syndrome

Altered sensory functioning is often observed in individuals with SHANK3 related Phelan-McDermid syndrome (PMS). Compared to typically developing individuals and individuals with an autism spectrum disorder, it has been suggested that there are distinctive features of sensory functioning in PMS.

Continue ReadingEuropean Consensus Recommendations on Altered Sensory Functioning in Phelan-McDermid syndrome